Capnography Devices Market Report 2026

Capnography Devices Market Overview

• Capnography Devices market size has reached to $0.83 billion in 2025 • Expected to grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 11.7% • Growth Driver: Rising Respiratory Disease Prevalence Drives Growth In Capnography Devices Market • Market Trend: Leading Companies Leverage Pilot Studies To Enhance Capnography Device Market Position • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Capnography Devices Market?

Capnography devices are medical instruments used to measure and monitor the concentration of carbon dioxide (CO2) in a patient's exhaled breath, providing real-time information about respiratory status, helping in the detection of respiratory conditions, ensuring proper ventilation, and guiding anesthetic management during surgeries. The main component types of capnography devices are original equipment manufacturer (OEM) modules and others. Original equipment manufacturer (OEM) modules in capnography devices are the components manufactured by one company and used in the final product made by another company. The products are hand-held, stand-alone, and multi-parameter, and the technologies used are mainstream, sidestream, and microstream. The applications of capnography devices are emergency medicine, pain management, procedural sedation, critical care, and others, and they are used by various end-users such as hospitals, ambulatory care, and others.

What Is The Capnography Devices Market Growth Forecast?

The capnography devices market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to rising prevalence of respiratory disorders, growing demand for continuous ventilation monitoring, expansion of ambulatory and outpatient procedures, increasing focus on early detection of respiratory compromise, rising adoption of capnography in non-hospital settings. Major trends in the forecast period include increasing adoption of capnography in emergency and critical care, rising use of capnography for procedural sedation monitoring, growing demand for portable and hand-held capnography devices, expansion of capnography use beyond operating rooms, increasing integration of capnography in multi-parameter monitors.

What Is The Driver Of The Capnography Devices Market?

The rising prevalence of respiratory diseases is expected to propel the growth of the capnography devices market going forward. Respiratory diseases are a group of medical conditions that affect the lungs and other parts of the respiratory system, including conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer, which impair breathing and can lead to severe health complications. The prevalence of respiratory diseases is rising due to factors such as increasing air pollution, smoking rates, and aging populations. Capnography devices are used in respiratory diseases to monitor and assess patients' ventilation status and detect abnormalities in real time. For instance, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Therefore, the rising prevalence of respiratory diseases is driving the growth of the capnography devices industry.

Key Players In The Global Capnography Devices Market

Major companies operating in the capnography devices market are Medtronic PLC, GE HealthCare Technologies Inc., Koninklijke Philips NV, Masimo Corporation, Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Mindray Medical International Limited, ZOLL Medical Corporation, Spacelabs Healthcare Inc., Vyaire Medical Inc., Edan Instruments Inc., Criticare Systems Inc., Opto Circuits India Limited, Infinium Medical Inc., Weinmann Emergency Medical Technology GmbH & Co. KG, BPL Medical Technologies Pvt Ltd., Smiths Group PLC, Nonin Medical Inc., Shenzhen Creative Industry Co Ltd, Shenzhen Comen Medical Instruments Co Ltd

Global Capnography Devices Market Trends and Insights

Major companies operating in the capnography devices market are increasing their focus on developing advanced pilot studies to gain a competitive edge in the market. Pilot studies are preliminary research investigations conducted to evaluate the feasibility, effectiveness, and potential impact of these devices in clinical settings. For instance, in March 2024, TidalSense, a UK-based respiratory device company, initiated a pilot study to assess its innovative N-Tidal device for diagnosing asthma in young children. The study, conducted in partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust, will involve 75 children under the age of five who are experiencing asthma and viral wheezing. The N-Tidal device uses capnography technology to measure carbon dioxide levels during normal breathing, eliminating the need for challenging spirometry tests often used in pediatric populations. These traditional tests can be difficult for young children, potentially leading to inaccurate diagnoses and prolonged hospital stays.

What Are Latest Mergers And Acquisitions In The Capnography Devices Market?

In September 2025, Masimo, a US-based medical technology company specializing in noninvasive monitoring solutions, partnered with Royal Philips, to integrate capnography measurements along with SedLine brain function monitoring. With this partnership, the companies aim to enhance advanced patient monitoring capabilities in operating rooms and intensive care units by combining Philips’ patient-monitoring platforms with Masimo’s innovative capnography and multimodal monitoring technologies to support more precise clinical decision-making and improved patient safety in critical-care environments. Royal Philips is a Netherlands-based health technology company.

What Defines the Capnography Devices Market?

The capnography devices market consists of sales of carbon dioxide (CO2) sensors, sampling lines, and display units. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Capnography Devices Market Report 2026?

The capnography devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the capnography devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.